Apoptotic Effect of Genistein on Hepatocellular Carcinoma HepG 2 Cell Line
Abstract
Hepatocellular carcinoma (HCC) is a major health problem and the sixth most common cancer worldwide. Although liver cancer is the sixth most common neoplasm worldwide, it’s very poor prognosis makes it the third leading cause of cancer-related mortality. This malignancy occurs more often among men than women, with the highest incidence rates reported in East Asia. GE (4',5,7-trihydroxyisoflavone), a phytoestrogenic compound and a major isoflavone constituent of soybeans and soy products, has been shown to suppress the growth of various cancers such as ovarian , oesophagus , breast , lung and colon cancers through modulation of various pathways. The aim of the present study was to analyse the apoptotic and antiprolifrative effect of genistein in the hepatocellular carcinoma HepG2 cell line. Materials and Methods: Cells were treated with various concentration of genistein and the MTT assay was used and then cells were treated with single dose of genistein (25μM) and flow cytometry assay was performed. Results: genistein inhibited the growth of liver cancer cells and induced apoptosis significantly with a time- and dose-dependent manner. Discussion: Our finding clearly indicated that genistein has a significant inhibitory effect and induces apoptosis with a dose- and time-dependent manner. Conclusion: genistein can significantly inhibit the growth of HCC cells and plays a significant role in apoptosis of this cell line.
Full Text:
PDFReferences
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, CA Cancer J Clin 2005; 55: 74–108.
El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340:745–50.
Sangiovanni A, Del Ninno E, Fasani P, et al. Increased survival of cirrhotic Patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126: 1005–14.
Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CACancer J Clin 2005; 55: 74 –108.
Ahmed F, Perz JF, Kwong S et al. National trends and disparities in the incidence of hepatocellular carcinoma, 1998 –2003. Prev Chronic Dis 2008; 5: A74.
Llovet JM. Updated treatment approach to hepatocellular carcinoma. J astroenterol 2005; 40: 225–235
Cancer Incidence in Five Continents, Vol. IX, in Curado MP, Edwards B, Shin HR, et al (eds): IARC Scientific Publications, 2007; 160: 371-8
El-Serag HB, Davila JA, Petersen NJ, et al: The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update. Ann Intern Med2003; 139:817-823
Espey DK, Wu XC, Swan J, et al: Annual report to the nation on the status of cancer, 1975- 2004, featuring cancer in American Indians and Alaska Natives. Cancer . 2007; 110: 2119-2152
Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD, National Cancer Institute, 2008. http://seer.cancer.gov/csr/1975_2005
London WT, McGlynn KA: Liver cancer, in Schottenfeld D, Fraumeni JF Jr (eds): Cancer Epidemiology and Prevention (ed 3). New York, NY, Oxford University Press, 2006, 763-786
Seeff LB: Introduction: The burden of hepatocellular carcinoma. Gastroenterology . 2004;127:1-4
Marion M and Zdenko H. From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms. Genome Medicine. 2012; 4: 186-195.
LIU Wei-ren, SHI Ying-hong, PENG Yuan-feiet al., Epigenetics of hepatocellular carcinoma: a new horizon. Chinese Medical Journal., 125(13), 2012, 2349-2360.
Regine Schneider-Stock, Akram G, Khuloud B et al., Epigenetic mechanisms of plant-derived anticancer drugs. Frontiers in Bioscience. 2012; 7: 129-173.
Yuanyuan Li, Syed MM, Shweta NPet al., Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer. Molecular Cancer. 2013; 12(9): 1186-1195.
Clinton DA, Kimberly FA, Young HJ et al., Dose-dependent Manner Growth of Estrogen-dependent (MCF-7) Tumors in a Soy Diets Containing Varying Amounts of Genistein Stimulate . Cancer Res. 2001; 61: 5045-5050.
Stefan O. Mueller, Stephanie Simon, Kun Chae, et al. Phytoestrogens and Their Human Metabolites Show Distinct Agonistic and Antagonistic Properties on Estrogen Receptor a (ERa) and ERb in Human Cells. Toxicological sciences. 2004; 80: 14–25
Ashish Kumar Sharma, Vipin Agarwal1, Bhupendra Chauhan1, et al. Role of phytoestrogen in treatment of cancer. International Journal of Pharma Research and Development. Publication Ref No.: IJPRD.2010; 2 (9): 22-32
Archana Sharma, Jyoti, Neerupma Dhiman, ShikhaSaxena. Health benefits of phytoestrogens. International Journal of Advanced Research .2014; 2 (4):1024-1030
Li, J. J., Li, S. A., Klicka, J. K., et al. Relative carcinogenic activity of various synthetic and natural estrogens in the hamster kidney. Cancer Res. 1983;4: 5200-5204.
Li. J. J., and Li, S. A. Estrogen-induced tumorigcnesis in the Syrian hamster: roles for hormonal and carcinogenic activities. Arch. Toxicol.1984; 55:110-118.
Li, J. J. and Li, S. A. Estrogen carcinogenesis in hamster tissues: role of metabolism. Fed. Proc.1987; 46: 1858-1863.
Xu H, Wei Y, Zhang Y, et al. (2012) Oestrogen attenuates tumour progression in hepatocellular carcinoma. J Pathol.2012; 228 (2): 216-229.
Erh-Jung Huang, Cheng-Chung Wu, Hsien-Ping Huang, et al. Apoptotic and anti-proliferative effects of 17β-estradiol and 17β-estradiol-like compounds in the Hep3B cell line. Molecular and Cellular Biochemistry. 2006; 290:1-7.
Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999; 80:827-841
Taylor-Robinson SD, Foster GR, Arora S, et al: Increase in primary liver cancer in the UK, 1979-94. Lancet. 1997; 350:1142-1143.
Deuffic S, Poynard T, Buffat L, et al: Trends in primary liver cancer. Lancet. 1998 ; 351:214-215.
Davis GL, Albright JE, Cook SF, et al: Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003; 9:331-338
Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000: The global picture. Eur J Cancer. 2001; 37: 4-66.
Smart RG, Mann RE, Suurvali H: Changes in liver cirrhosis death rates in different countries in relation to per capita alcohol consumption and Alcoholics Anonymous membership. J Stud Alcohol. 1998; 59:245-249.
Peeters PH, Keinan-Boker L, van der Schouw YT and Grobbee DEL: Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat. 2003; 77: 171-183.
Lee MM, Gomez SL, Chang JS, Wey M, Wang RT and Hsing AW: Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 2003; 12: 665-668.
Hsieh C-Y, Santell RC, Haslam SZ and Helferich WG: Estrogenic effects of genistein on the growth of estrogen receptor positive human breast cancer (MCF-7) cells in vitro and in vivo. Anticancer Res. 1998; 58: 3833-3838.
Dampier K, Hudson EA, Howells LM, Manson MM, Walker RA and Gescher A: Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. Br J Cancer. 2001; 85: 618-624.
Schwarz JA, Liu G and Brooks SC: Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes. Biochem Biophys Res Commun. 1998 253:38-43.
Lamartiniere CA: Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr Suppl. 2000; 71: 1705-1707.
Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson JA, Khan G and Hilakivi-Clarke L: Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis. 2004; 25: 741-748.
Lamartiniere CA, Zhang J-X and Cotroneo MS: Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Am J Clin Nutr Supp. 1998; l68: 1400-1405.
Li Y, Bhuiyan M and Sarkar FH: Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein. Int J Oncol. 1999; 15: 525-533.
Bergan R, Kyle E, Nguyen P, Trepel J, Ingui C, Neckers L. Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to h-1-integrin. Clin Exp Metastasis 1996;14: 389–98.
Liu YU, Kyle E, Lieberman R, Crowell J, Kelloff G, Bergan RC. Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-b-1-integrin complex formation. Clin Exp Metastasis 2000;18: 203–12.
Huang X, Chen S, Xu L, et al. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res 2005; 65: 3470–8.
Xu L, Bergan RC. Genistein inhibits MMP-2 activation and prostate cancer cell invasion by blocking TGF{h}-mediated activation of MAPKAPK2–27 pathway. Mol Pharmacol 2006; 70: 869–77.
Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and assocaitions. Scand J Clin Lab Invest 1990; 50 Suppl 201:3–23.
Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63: 963–6.
Severson RK, Nomura AM, Grove JS, Stemmermann GN. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989; 49:1857–60.
Cook LS, Goldoft M, Schwartz SM, Weiss NS. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 1999;161:152–5.
Zhou, J. R., Gugger, E. T., Tanaka, T., Guo, Y., Blackburn, G. L., and Clinton, S. K. Soybeans phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J. Nutr. 1999; 129: 1628–1635.
Davis, J. N., Singh, B., Bhuiyan, M., and Sarkar, F. H. Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr. Cancer. 1998; 32: 123–131.
Dalu, A., Haskell, J. F., Coward, L., and Lamartiniere, C. A. Genestein, a component of soy, inhibits the expression of the EGF, and ErbB2/Neu receptors in the rat dorsolateral prostate. Prostate. 1998; 37: 36–43.
Messina M, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of in vitro and in vivo data. Nutr Cancer 1994; 21:113–31.
Zhang M, Xie X, Lee AH, Binns CW. Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast China. Nutr Cancer 2004; 49:125–30.
Krishnan HB. Identification of genistein, an anticarcinogenic compound, in the edible tubers of the American groundnut (Apios americana medikus). Crop Sci 1998; 38:1052–6.
Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995; 125: 777–83.
Cai QY, Rahn RO, Zhang RW. Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals. Cancer Lett 1997; 119: 99–107.
Barnes S, Grubbs C, Setchell KD, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res 1990; 347:239–53.
Hawrylewicz EJ, Huang HH, Blair WH. Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr 1991;121:1693–8.
Wang J, Eltoum IE, Lamartiniere CA. Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats. Cancer Lett 2002;186:11–8.
Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 2002; 132: 552–8.
Steele VE, Pereira MA, Sigman CC, Kelloff GJ. Cancer chemoprevention agent development strategies for genistein. J Nutr 1995; 125: 713–6S.
Kallay E, Adlercreutz H, Farhan H, et al. Phytoestrogens regulate vitamin D metabolism in the mouse colon: relevance for colon tumor prevention and therapy. J Nutr 2002; 132: 3490–3.
Tamura S, Bito T, Ichihashi M, Ueda M. Genistein enhances the cisplatin-induced inhibition of cell growth and apoptosis in human malignant melanoma cells. Pigment Cell Res 2003;16: 470–6.
Abdalla A, Darwish AS, Elbanhawy R, Ghouraba A, Shehata S. Hepatocellular carcinoma: An overview of disease epidemiology and risk factors. Intern J Allied Med Sci Clin Res 2014; 2: 205-9.
Nigam N, George J, Srivastava S, Roy P, Bhui K, Singh M, et al. Induction of apoptosis by [6]‑gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a] P‑induced mouse skin tumorigenesis. Cancer Chemother Pharmacol 2010; 65:687‑96.
Chen AC, Donovan SM. Genistein at a concentration present in soy infant formula inhibits 50 caco‑2BBe cell proliferation by causing G2/M cell cycle arrest1. Biochemical and molecular actions of nutrients. J Nutr 2004;134:1303‑8.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright ©2022 Academic Journals Center
To make sure that you can receive messages from us, please add the 'academicjournalscenter.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.